http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103380128-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 |
| filingDate | 2011-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103380128-B |
| titleOfInvention | Crystal formation and preparation method thereof |
| abstract | The present invention relates to 1 [(3R) 6,8 difluoros 3,4 dihydro 2H, 1 .alpha.-5:6-benzopyran 3 base] 1, crystal formation A and 1 [(3R) 6 of 3 dihydro 5 [2 [(phenyl methyl) amino] ethyl] 2H imidazoles 2 thioketone, 8 difluoros 3,4 dihydro 2H, 1 .alpha.-5:6-benzopyran 3 base] the crystal formation B of 1,3 dihydro 5 [2 [(phenyl methyl) amino] ethyl] 2H imidazoles 2 thioketone, the preparation method of described crystal formation and their applications in medicine.The invention still further relates to 1 [(3R) 6,8 difluoros 3,4 dihydro 2H, 1 .alpha.-5:6-benzopyran 3 base] 1,3 dihydro 5 [2 [(phenyl methyl) amino] ethyl] the armorphous, its preparation method of 2H imidazoles 2 thioketone and its application in medicine. |
| priorityDate | 2010-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.